Journal Of Personalized Medicine

Journal Title：Journal Of Personalized Medicine

Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.

《个性化医学杂志》（JPM；ISSN 2075-4426）是一本国际性开放获取期刊，旨在将个性化医学的各个方面集中到一个平台上。JPM 发表与个性化医学相关的前沿、创新性临床前和转化科学研究和技术（例如药物基因组学/蛋白质组学、系统生物学）。JPM 认识到个性化医学（评估导致个体差异的遗传、环境和宿主因素）是一个具有挑战性的跨学科主题，需要一系列专家的讨论。为了全面了解个性化医学，JPM 旨在整合分子和转化科学、治疗学和诊断学的专业知识，以及监管、社会、伦理和政策方面的讨论。我们提供一个论坛，将学术和临床研究人员、生物技术、诊断和制药公司、卫生专业人员、监管和伦理专家以及政府和监管机构聚集在一起。

Journal Of Personalized Medicine创刊于2011年，由Multidisciplinary Digital Publishing Institute (MDPI)出版商出版，收稿方向涵盖Medicine - Medicine (miscellaneous)全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度约First decision after submission: 20.2 days; Acceptance to publication: 1.9 days 11 Weeks ，影响因子指数3，该期刊近期被列入国际期刊预警名单，请广大学者慎重选择。